NanoMedical Systems Revenue

Nanotechnology Research • Austin, Texas, United States • 1-10 Employees

NanoMedical Systems revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$625,000
Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$3,000,000

Key Contacts at NanoMedical Systems

Michael Matula

Chief Executive Officer

Ryan Prince

Director Of Research Development

Company overview

Headquarters	12708 Riata Vista Circle, Suite A-105, Austin, Texas 78727, US
Phone number	+15126144434
Website	nanomedsys.com
NAICS	541713
SIC	873
Keywords	Nanotechnology, Nanomedicine, Drug Delivery, Semiconductor Fabrication, Bioanalytical Sample Preparation, Drug Delivery Implants, Peptide Enhancement, Peptide Enrichment, Peptide Extraction, Silica Nanopores, Silicon Nanochannels, Sustained Drug Delivery, The New Pharma, Cgmp Manufacturing - Silicon Devices, Nanotechnology Transforming Drug Delivery
Founded	2008
Employees	1-10
Socials

NanoMedical Systems Email Formats

NanoMedical Systems uses 1 email format. The most common is {last name}{last name} (e.g., doedoe@nanomedsys.com), used 100% of the time.

Format	Example	Percentage
{last name}{last name}	doedoe@nanomedsys.com	100%

About NanoMedical Systems

NanoMedical Systems develops novel drug-delivery devices based on its proprietary nStrada™ nanofluidics platform for sustained release of chronic therapies. These devices can be loaded with a variety of drugs including small molecules, peptides, and proteins for subcutaneous implantation. The nStrada™ devices rely on diffusion (passive or controlled) to achieve steady-state drug concentrations within a few days and then maintain constant release for the duration of the implant. This performance represents a significant improvement over polymer-based implants and depots which suffer from an initial burst release and multiple weeks to achieve steady-state concentrations.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

NanoMedical Systems has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore NanoMedical Systems's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-09-14	9	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

NanoMedical Systems Tech Stack

Discover the technologies and tools that power NanoMedical Systems's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Gravity Forms

Form builders

ElementsKit

WordPress plugins

Elementor Header & Footer Builder

WordPress plugins

Google Maps

Maps

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

Calendly

Appointment scheduling

Frequently asked questions

NanoMedical Systems is located in Austin, Texas, US.

You can reach NanoMedical Systems at +15126144434.

NanoMedical Systems generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

NanoMedical Systems has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NanoMedical Systems was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

NanoMedical Systems has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

NanoMedical Systems has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at NanoMedical Systems

Michael Matula

Chief Executive Officer

Ryan Prince

Director Of Research Development

4.8

40,000 users